Form 4: Perrigo Executive Receives Restricted Stock Units

Charles Atkinson, EVP and General Counsel of Perrigo Company plc, was granted 46,093 restricted stock units.

Summary

• Charles Atkinson, EVP, General Counsel & Secretary of Perrigo Company plc, received a grant of 46,093 restricted stock units (RSUs) on May 13, 2026.
• Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
• The RSUs are scheduled to vest in three equal annual installments beginning on May 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation with no immediate impact on company operations or financial health.

Positives

• The grant aligns executive compensation with long-term shareholder interests through a multi-year vesting schedule.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market fluctuations in Perrigo's share price.

Future Outlook

The RSUs will vest in three equal annual installments starting May 13, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity grants to key executives are standard corporate governance practices intended to incentivize long-term retention and performance alignment within the pharmaceutical and consumer health sectors.

Comparison to Industry Standards

• The use of three-year graded vesting for executive equity is consistent with standard compensation practices among large-cap pharmaceutical companies.
• The grant structure is typical for an EVP-level officer in a publicly traded company.

Stakeholder Impact

• Shareholders may view the equity grant as a standard retention mechanism for senior leadership.

Next Steps

• Vesting of the first tranche of RSUs on May 13, 2027.

Key Dates

Keywords

Perrigo, PRGO, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units